Search results for "9R"

showing 10 items of 10 documents

CCDC 285889: Experimental Crystal Structure Determination

2006

Related Article: B.Frackowiak, K.Ochalik, A.Bialonska, Z.Ciunik, C.Wawrzenczyk, S.Lochynski|2006|Tetrahedron:Asymm.|17|124|doi:10.1016/j.tetasy.2005.11.025

(1S3S7S9R)-(+)-1010-Dimethyl-3-iodomethyl-4-oxatricyclo(7.1.0^19^.0^37^)decan-5-oneSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 285890: Experimental Crystal Structure Determination

2006

Related Article: B.Frackowiak, K.Ochalik, A.Bialonska, Z.Ciunik, C.Wawrzenczyk, S.Lochynski|2006|Tetrahedron:Asymm.|17|124|doi:10.1016/j.tetasy.2005.11.025

(1S3S7S9R)-(+)-3-Bromomethyl-1010-dimethyl-4-oxatricyclo(7.1.0^19^.0^37^)decan-5-oneSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients

2016

Summary Cytokines such as tumour necrosis factor (TNF)-α, interleukin (IL)-12, interferon (IFN)-γ, IL-23 and, more recently, IL-9, have been implicated in the initiation/maintenance of inflammation in psoriasis and psoriatic arthritis (PsA). In the present study we aimed to characterize the role of γδ T cells in peripheral blood and synovial fluid of PsA patients and to investigate their response to in-vitro stimulation with antigen or cytokines (IL-9 and IL-23). γδ T cells isolated from peripheral blood mononuclear cells and synovial fluid were analysed by flow cytometry to evaluate the phenotype and cytokine production. IL-23R and IL-9R gene expression were also evaluated by reverse trans…

AdultMale0301 basic medicinepsoriatic arthritimedicine.medical_treatmentImmunologyInflammationLymphocyte ActivationSeverity of Illness IndexPeripheral blood mononuclear cellImmunophenotypingγδ-T cellsYoung Adult03 medical and health sciences0302 clinical medicineAntigenT-Lymphocyte SubsetsInterferonSynovial FluidmedicineHumansImmunology and AllergySynovial fluidAgedReceptors Interleukin-9psoriatic arthritis030203 arthritis & rheumatologybusiness.industryArthritis PsoriaticInterleukin-9InterleukinReceptors Antigen T-Cell gamma-deltaOriginal ArticlesIL-9; IL-9R; psoriatic arthritis; γδ-T cells; Immunology and Allergy; ImmunologyMiddle AgedIL-9IL-9RSettore MED/16 - ReumatologiaPhenotype030104 developmental biologyCytokineImmunologyFemaleTumor necrosis factor alphamedicine.symptombusinessBiomarkersmedicine.drugClinical and Experimental Immunology
researchProduct

CCDC 618136: Experimental Crystal Structure Determination

2006

Related Article: M.A.Gonzalez, M.J.Gil-Gimeno, A.J.Blake|2006|Acta Crystallogr.,Sect.E:Struct.Rep.Online|62|o3346|doi:10.1107/S1600536806026705

Space GroupCrystallography(4R5R9R10R)-713-Abietadien-18-yl p-bromobenzoateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 654035: Experimental Crystal Structure Determination

2007

Related Article: Xue-Mei Niu, Sheng-Hong Li, Helmar Gorls, D.Schollmeyer, M.Hilliger, S.Grabley, I.Sattler|2007|Org.Lett.|9|2437|doi:10.1021/ol0705999

Space GroupCrystallographyCrystal SystemCrystal Structure(2R3R4R4aS5R5aS7R9R12aR12bS)-4710-Trihydroxy-5-methoxy-279-trimethyl-12-oxo-12344a55a67891112a12b-tetradecahydrobenzo(g)cyclo-octa(cd)pentalene-611-dione methanol solvateCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 608116: Experimental Crystal Structure Determination

2008

Related Article: I.Moldvai, E.Gacs-Baitz, E.Termesvari-Major, L.Russo, I.Papai, K.Rissanen, E.Szarics, J.Kardos, C.Szantay|2007|Heterocycles|71|1075|doi:10.3987/COM-07-11011

Space GroupCrystallographyCrystal SystemCrystal Structure(6aR6'aR9R9'R)-dimethyl 77'-dimethyl-44'66a6'6a'77'88'99'-dodecahydro-99'-biindolo(43-fg)quinoline-99'-dicarboxylate ethyl acetate hemihydrateCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 605711: Experimental Crystal Structure Determination

2006

Related Article: A.J.Blake, M.A.Gonzalez, M.J.Gil-Gimeno|2006|Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.|62|o208|doi:10.1107/S0108270106006366

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(-)-(5S8S9R10S13R14R)-15-Acetoxy-1516-dideoxy-1617-epoxyspongian-16-oneExperimental 3D Coordinates
researchProduct

CCDC 206152: Experimental Crystal Structure Determination

2003

Related Article: Derong Cao, S.Dobis, D.Schollmeyer, H.Meier|2003|Tetrahedron|59|5323|doi:10.1016/S0040-4020(03)00787-7

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(5R*9R*)-79-Dimethoxy-3-oxahexacyclo-(8.6.6.1^59^.0^15^.0^1116^.0^1722^)tricosa-6111315171921-heptaen-8-one cyclohexane solvateExperimental 3D Coordinates
researchProduct

CCDC 685194: Experimental Crystal Structure Determination

2009

Related Article: O.Bassas, J.Huuskonen, K.Rissanen, A.M.P.Koskinen|2009|Eur.J.Org.Chem.|2009|1340|doi:10.1002/ejoc.200801220

Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D CoordinatesN-((9R)-6'-Methoxycinchonan-9-yl)-N'-(9-phenylfluoren-9-yl)thiourea
researchProduct

Assessment of genetically modified oilseed rape MS8, RF3 and MS8×RF3 for renewal of authorisation under regulation (EC) No 1829/2003 (application EFS…

2017

Efsa Panel On Genetically Modified Organisms (gmo)Opinion scientificRequestor: European CommissionQuestion number: EFSA-Q-2016-00569; Following the submission of application EFSA-GMO-RX-004 under Regulation (EC) No 1829/2003 from Bayer CropScience, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the genetically modified (GM) herbicide-tolerant oilseed rape MS8, RF3 and MS89RF3. The data received in the context of this renewal application contain post-market environmental monitoring reports, systematic searches and…

oilseed rapeoilseed rape;MS8;RF3 and MS89RF3;renewal;articles 11 and 23;Regulation (EC) No 1829/2003040301 veterinary sciencesgmo[SDV]Life Sciences [q-bio]Veterinary (miscellaneous)ogmContext (language use)Plant Science010501 environmental sciencesOriginal ApplicationMS801 natural sciencesMicrobiologyarticles 11 and 230403 veterinary sciencearticles 11 and 23RF3 and MS8×RF30105 earth and related environmental sciencesoilseedrenewal2. Zero hungerbusiness.industryRegulation (EC) No 1829/2003Authorization10079 Institute of Veterinary Pharmacology and Toxicology04 agricultural and veterinary sciencesFood safetyBiotechnologyGenetically modified organismRF3 and MS89RF3Scientific OpinionRF3 and MS8xRF3Regulation (EC) No1829/2003570 Life sciences; biologygraine oléagineuseAnimal Science and ZoologyParasitologybusinessRisk assessmentRegulation (EC) No 1829/2003Food Science
researchProduct